<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (.NO) generation from conversion of l-arginine to <z:chebi fb="0" ids="18211">citrulline</z:chebi> by nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase isoforms plays a critical role in vascular homeostasis </plain></SENT>
<SENT sid="1" pm="."><plain>Loss of .NO is linked to vascular pathophysiology and is decreased in chronically inflamed gut blood vessels in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD; <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>) </plain></SENT>
<SENT sid="2" pm="."><plain>Mechanisms underlying decreased .NO production in IBD gut microvessels are not fully characterized </plain></SENT>
<SENT sid="3" pm="."><plain>Loss of .NO generation may result from increased arginase (AR) activity, which enzymatically competes with nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase for the common substrate l-arginine </plain></SENT>
<SENT sid="4" pm="."><plain>We characterized AR expression in IBD microvessels and endothelial cells and its contribution to decreased .NO production </plain></SENT>
<SENT sid="5" pm="."><plain>AR expression was assessed in resected gut tissues and human intestinal microvascular endothelial cells (HIMEC) </plain></SENT>
<SENT sid="6" pm="."><plain>AR expression significantly increased in both <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> microvessels and submucosal tissues compared with <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>TNF-alpha/<z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> increased AR activity, <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expression in HIMEC in a time-dependent fashion </plain></SENT>
<SENT sid="8" pm="."><plain>RhoA/ROCK pathway, a negative regulator of .NO generation in endothelial cells, was examined </plain></SENT>
<SENT sid="9" pm="."><plain>The RhoA inhibitor C3 exoenzyme and the ROCK inhibitor Y-27632 both attenuated TNF-alpha/<z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi>-induced MAPK activation and blocked AR expression in HIMEC </plain></SENT>
<SENT sid="10" pm="."><plain>A significantly higher AR activity and increased RhoA activity were observed in IBD submucosal tissues surrounding microvessels compared with <z:mpath ids='MPATH_458'>normal</z:mpath> control gut tissue </plain></SENT>
<SENT sid="11" pm="."><plain>Functionally, inhibition of AR activity decreased leukocyte binding to HIMEC in an <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> assay </plain></SENT>
<SENT sid="12" pm="."><plain>Loss of .NO production in IBD microvessels is linked to enhanced levels of AR in intestinal endothelial cells exposed to <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> in vivo </plain></SENT>
</text></document>